Valuation: China Shineway Pharmaceutical Group Limited

Market Cap 472.14Cr 552.58Cr 70Cr 63Cr 58Cr 53Cr 100.38Cr 6.77TCr 101.32Cr 706.68Cr 273.84Cr 3.46TCr 264.38Cr 258.64Cr 11TCr P/E 2026 *
6.25x
P/E 2027 * 5.82x
Enterprise Value 472.14Cr 552.58Cr 70Cr 63Cr 58Cr 53Cr 100.38Cr 6.77TCr 101.32Cr 706.68Cr 273.84Cr 3.46TCr 264.38Cr 258.64Cr 11TCr EV / Sales 2026 *
2.01x
EV / Sales 2027 * 2.01x
Free-Float
33.69%
Yield 2026 *
-
Yield 2027 * -
1 day-0.41%
1 week-12.71%
Current month-12.29%
1 month-10.25%
3 months-0.88%
6 months-25.05%
Current year-14.94%
1 week 7.12
Extreme 7.12
8.56
1 month 7.12
Extreme 7.12
8.56
Current year 7.12
Extreme 7.12
10.47
1 year 7.12
Extreme 7.12
10.47
3 years 6.55
Extreme 6.55
10.76
5 years 4.63
Extreme 4.63
10.76
10 years 4.6
Extreme 4.6
18.54
Manager TitleAgeSince
Investor Relations Contact 60 -
Sales & Marketing 46 01/12/2019
Comptroller/Controller/Auditor 53 01/02/2011
Director TitleAgeSince
Chairman 70 14/08/2002
Director/Board Member 58 -
Director/Board Member 50 01/10/2020
Date Insider Type Main position Quantity % Market Cap. Importance
31/10/22 Other

Director

2,80,000 0.0339%
Change 5-day change 1-year change 3-year change Capi.($)
-0.41%-12.71%-13.02%-6.58% 70Cr
-0.61%-3.43%+39.40%+112.31% 1,01900Cr
-1.02%-5.60%+37.67%+65.02% 62TCr
+1.11%-0.58%+11.10%+77.28% 46TCr
+0.34%-3.01%+61.21%+40.71% 36TCr
-0.95%-4.05%+21.60%+39.37% 33TCr
-1.46%-2.89%+11.84%+24.60% 27TCr
-1.35%-5.43%-4.69%+8.40% 24TCr
-1.04%-2.79%+35.52%+51.34% 22TCr
-1.87%-4.10%+30.92%+95.33% 18TCr
Average -0.25%-4.32%+23.15%+50.78% 36.98TCr
Weighted average by Cap. +0.42%-3.33%+30.51%+68.94%

Financials

2026 *2027 *
Net sales 234.4Cr 274.34Cr 35Cr 31Cr 29Cr 26Cr 50Cr 3.36TCr 50Cr 350.85Cr 135.95Cr 1.72TCr 131.26Cr 128.41Cr 5.51TCr 234.7Cr 274.69Cr 35Cr 31Cr 29Cr 26Cr 50Cr 3.37TCr 50Cr 351.29Cr 136.13Cr 1.72TCr 131.43Cr 128.57Cr 5.52TCr
Net income 76Cr 88Cr 11Cr 10Cr 9.34Cr 8.51Cr 16Cr 1.08TCr 16Cr 113.01Cr 44Cr 553.39Cr 42Cr 41Cr 1.78TCr 81Cr 95Cr 12Cr 11Cr 10Cr 9.14Cr 17Cr 1.16TCr 17Cr 121.39Cr 47Cr 594.44Cr 45Cr 44Cr 1.91TCr
Net Debt - -
Logo China Shineway Pharmaceutical Group Limited
China Shineway Pharmaceutical Group Ltd is an investment holding company primarily engaged in research and development, manufacturing and trading of Chinese pharmaceutical products. The Company’s product dosage forms include injections, soft capsules, granules, traditional Chinese medicine (TCM) granules, oral products and other dosage forms. The Company’s products include Qing Kai Ling Injection, Shen Mai Injection, Wu Fu Xin Nao Qing Soft Capsule, Qing Kai Ling Soft Capsule, Huamoyan Granule, Compound Licorice Tablet and other products, applied to influenza, cardio-cerebrovascular, respiratory system and other disease fields. The Company operates its business in mainland China and Hong Kong markets.
Employees
2,656
Date Price Change Volume
02/26/02 HK$7.315 -12.29% 24,31,190
30/26/30 HK$8.340 -0.42% 39,37,453
29/26/29 HK$8.375 -1.24% 22,84,000
28/26/28 HK$8.480 +1.19% 25,61,000
25/26/25 HK$8.380 +0.30% 4,87,000
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
6.250CNY
Average target price
7.294CNY
Spread / Average Target
+16.70%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2877 Stock